Δ9-Tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis
- 1 June 1989
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 23 (1) , 73-81
- https://doi.org/10.1016/0165-5728(89)90075-1
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Tetrahydrocannabinol for tremor in multiple sclerosisAnnals of Neurology, 1983
- Hyperbaric-Oxygen Treatment of Multiple SclerosisNew England Journal of Medicine, 1983
- Effects of Δ9-Tetrahydrocannabinol, Cannabinol and Cannabidiol on the Immune System in MicePharmacology, 1983
- Multiple sclerosis: Trial of a synthetic polypeptideAnnals of Neurology, 1982
- Effects of Cannabinoids Given Orally and Reduced Appetite on the Male Rat Reproductive SystemPharmacology, 1982
- TRANSFER FACTOR IN TREATMENT OF MULTIPLE SCLEROSISThe Lancet, 1980
- Immunosuppressive drugs in multiple sclerosisNeurology, 1980
- Multiple Sclerosis Treated with Antithymocyte Globulin — A Five Year Follow-UpCanadian Journal of Neurological Sciences, 1978
- CHANGES IN RAT ADRENAL MEDULLA FOLLOWING Δ9-TETRAHYDROCANNABINOL TREATMENT. A HISTOCHEMICAL STUDYActa Endocrinologica, 1975
- Effects of Δ9-Tetrahydrocannabinol and Cannabinol in ManPharmacology, 1975